Recursion Pharmaceuticals

About Recursion Pharmaceuticals

Recursion Pharmaceuticals is a pioneering biotechnology company based in the UK, dedicated to transforming drug discovery through advanced technology and data science. Our mission is to harness the power of artificial intelligence and machine learning to accelerate the development of new therapeutics for various diseases.

At Recursion, we believe that the future of medicine lies in the integration of biology and technology. We utilise a unique platform that combines high-throughput biology with cutting-edge computational techniques to identify potential drug candidates more efficiently than traditional methods.

• Innovative Approach: Our approach allows us to explore vast biological datasets, uncovering insights that lead to novel therapeutic targets.
• Collaborative Partnerships: We actively collaborate with academic institutions and pharmaceutical companies to enhance our research capabilities and broaden our impact.
• Focus on Rare Diseases: We are particularly committed to addressing unmet medical needs in rare diseases, where traditional drug development has often fallen short.

Our team comprises experts from diverse fields, including biology, engineering, and data science, all united by a common goal: to improve patient outcomes through innovative therapies. We are driven by a culture of curiosity and collaboration, fostering an environment where groundbreaking ideas can flourish.

As we continue to grow, Recursion Pharmaceuticals remains steadfast in our commitment to ethical practices and transparency in all our operations. We aim to not only advance science but also to make a meaningful difference in the lives of patients around the world.